Status:
COMPLETED
The Effects of tDCS on Auditory Hallucination, Insight, Neurocognitive Function and HRV in Patients With Schizophrenia
Lead Sponsor:
Tri-Service General Hospital
Conditions:
Schizophrenia
Schizoaffective Disorder
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
The study aimed to investigate whether transcranial direct current stimulation could modify auditory hallucination, insight, neurocognitive function, heart rate variability, psychosocial functioning a...
Detailed Description
Transcranial direct current stimulation (tDCS), a novel, non-invasive and safe neuro-modulating technique, has been developed as a new therapeutic option for neuropsychiatric disorders. It encompasses...
Eligibility Criteria
Inclusion
- \- Patients who met DSM-IV-TR criteria for schizophrenia or schizoaffective disorder were included in the study. All these patients showed refractory auditory verbal hallucinations,which are defined as the persistence of daily auditory verbal hallucinations without remission in spite of antipsychotic medications at an adequate dosage for at least 3 months.
Exclusion
- Pregnancy or breastfeeding.
- Having epilepsy, severe physical illness, any current psychiatric comorbidity or history of substance dependence.
- Having contraindications for transcranial electrical/magnetic stimulation.
- Having intracranial metal foreign bodies.
- Having a history of intracranial neoplasms or surgery, or a history of severe head injuries or cerebrovascular diseases.
Key Trial Info
Start Date :
July 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 2 2018
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03388554
Start Date
July 1 2016
End Date
March 2 2018
Last Update
May 1 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tri-service general hospital
Taipei, Taiwan, 114